These findings advocate for the necessity to profile the expression of the dystrophin isoforms in post-mortem brain samples from people with dystrophinopathies in order to elucidate the transcriptional mechanisms underlying the behavioural and learning problems in DMD. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.